伊克泽珠单抗
斑块性银屑病
医学
银屑病
白细胞介素17
免疫学
皮肤病科
白细胞介素
单克隆抗体
银屑病性关节炎
单克隆
炎症
抗体
塞库金单抗
细胞因子
作者
Craig L. Leonardi,Robert Matheson,Claus Zachariae,Gregory S. Cameron,Linda Li,Emily Edson‐Heredia,Daniel Braun,Subhashis Banerjee
标识
DOI：10.1056/nejmoa1109997
摘要
Use of a humanized anti-interleukin-17 monoclonal antibody, ixekizumab, improved the clinical symptoms of psoriasis. Further studies are needed to establish its long-term safety and efficacy in patients with psoriasis. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT01107457.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
yjh123
无极微光
Kao
忧郁翠彤
Nexus
Copyright
xjcy
潇洒的惋清
cdercder
phdchem
烟消云散
Criminology34
GingerF
Avalonx
OK
烂漫的碧玉
疯狂加载ing
pluto
xyz
Yangyang
皖公网安备34019202002308
